Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebeca Mayo

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Proteome Research|August 6, 2010
Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver diseaseJonathan Barr, Mercedes Vázquez-Chantada, Cristina Alonso, et al.
Hepatology (Baltimore, Md.)|July 28, 2023
Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)Mazen Noureddin, Emily Truong, Rebeca Mayo, et al.
Journal of Hepatology|February 15, 2022
Inhibition of carnitine palmitoyltransferase 1A in hepatic stellate cells protects against fibrosisMarcos F Fondevila, Uxia Fernandez, Violeta Heras, et al.
Hepatology Communications|July 21, 2018
Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohortsRebeca Mayo, Javier Crespo, Ibon Martínez-Arranz, et al.
Hepatology Communications|November 22, 2017
Role of Aramchol in steatohepatitis and fibrosis in miceMarta Iruarrizaga-Lejarreta, Marta Varela-Rey, David Fernández-Ramos, et al.
Gastroenterology|January 31, 2017
Metabolomic Identification of Subtypes of Nonalcoholic SteatohepatitisCristina Alonso, David Fernández-Ramos, Marta Varela-Rey, et al.
Hepatology (Baltimore, Md.)|February 27, 2022
Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profilesIbon Martínez-Arranz, Chiara Bruzzone, Mazen Noureddin, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Proteome Research|August 6, 2010
Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver diseaseJonathan Barr, Mercedes Vázquez-Chantada, Cristina Alonso, et al.
Hepatology (Baltimore, Md.)|July 28, 2023
Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)Mazen Noureddin, Emily Truong, Rebeca Mayo, et al.
Journal of Hepatology|February 15, 2022
Inhibition of carnitine palmitoyltransferase 1A in hepatic stellate cells protects against fibrosisMarcos F Fondevila, Uxia Fernandez, Violeta Heras, et al.
Hepatology Communications|July 21, 2018
Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohortsRebeca Mayo, Javier Crespo, Ibon Martínez-Arranz, et al.
Hepatology Communications|November 22, 2017
Role of Aramchol in steatohepatitis and fibrosis in miceMarta Iruarrizaga-Lejarreta, Marta Varela-Rey, David Fernández-Ramos, et al.
Gastroenterology|January 31, 2017
Metabolomic Identification of Subtypes of Nonalcoholic SteatohepatitisCristina Alonso, David Fernández-Ramos, Marta Varela-Rey, et al.
Hepatology (Baltimore, Md.)|February 27, 2022
Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profilesIbon Martínez-Arranz, Chiara Bruzzone, Mazen Noureddin, et al.
Pageof 2